Tuesday, April 01, 2025 9:16:27 AM
Recent CMPX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 12:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 12:30:29 PM
- Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/05/2026 12:30:00 PM
- The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era • GlobeNewswire Inc. • 01/14/2026 03:39:59 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/08/2026 05:15:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 01:00:54 PM
- Compass Therapeutics Provides Corporate Update • GlobeNewswire Inc. • 01/06/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:33:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:33:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:33:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:32:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:32:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:31:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:30:55 PM
- Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/05/2026 09:30:00 PM
- Compass Therapeutics Announces Key Leadership Appointments • GlobeNewswire Inc. • 01/05/2026 01:00:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/31/2025 09:02:35 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/30/2025 09:02:48 PM
- Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference • GlobeNewswire Inc. • 12/17/2025 12:30:00 PM
- Compass Therapeutics to Participate in Upcoming December Investor Events • GlobeNewswire Inc. • 11/25/2025 01:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2025 11:35:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 12:30:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:30:29 PM
- Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
